The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with reductions in risk-adjusted ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Among GLP-1 RA ever-users, there was no increased risk ... to patients and clinicians about the short-term safety of these drugs,” the authors write. “Nevertheless, evidence was insufficient ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...

Only 34 of 79 websites stated that compounded drugs were not FDA approved ... The researchers found that 98 unique websites sold any GLP-1 RA during the study period; the analysis included ...